(Q33286793)

English

Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

0 references

Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Marcello Tiseo

3

0 references

12

object named as

Rafael Rosell

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Frank V Fossella

4

object named as

Frank V Fossella

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Andrea Ardizzoni

1

object named as

Andrea Ardizzoni

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

Luca Boni

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Joan H Schiller

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Marianne Paesmans

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Davorin Radosavljevic

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Adriano Paccagnella

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Petr Zatloukal

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Paola Mazzanti

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Donald Bisset

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

CISCA (CISplatin versus CArboplatin) Meta-analysis Group

13

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

1 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Journal of the National Cancer Institute

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

847-857

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE).

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK196

21 January 2018

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK196

21 January 2018

Carboplatin versus cisplatin in solid tumors: an analysis of the literature

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK196

21 January 2018

Is cisplatin still the best platinum compound in non-small-cell lung cancer?

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK196

21 January 2018

Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK196

21 January 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK196

21 January 2018

Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analyses.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK196

21 January 2018

Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK196

21 January 2018

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK196

21 January 2018

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK196

21 January 2018

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK196

21 January 2018

Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK196

21 January 2018

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK196

21 January 2018

American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK196

21 January 2018

Meta-analyses based on abstracted data: a step in the right direction, but only a first step.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK196

21 January 2018

Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK196

21 January 2018

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC)

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK196

21 January 2018

Identifiers

10.1093/JNCI/DJK196

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33286793&oldid=1961230388"